Herbas VPB

Print
EN | LT
LT - METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE
EN - METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 29/00
A61K 9/107
A61K 47/12
A61K 47/14
European patent
(11) Number of the document 2613809
(13) Kind of document T
(96) European patent application number 11760887.7
Date of filing the European patent application 2011-09-12
(97) Date of publication of the European application 2013-07-17
(45) Date of publication and mention of the grant of the patent 2019-07-24
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2011/001567
Date 2011-09-12
PCT application publication
(87) Number WO 2012/033538
Date 2012-03-15
Priority applications
(30) Number Date Country code
923257 2010-09-10 US
Inventors
(72)
DRISCOLL, David F., US
Grantee
(73) Stable Solutions LLC, 551 Mills Way, Goleta, California 93117, US
Title
(54) METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE
  METHOD OF MITIGATING ADVERSE DRUG EVENTS USING OMEGA-3 FATTY ACIDS AS A PARENTERAL THERAPEUTIC DRUG VEHICLE
Last update date 2021-04-30